Skip to content

Faculty profile

Brenda Hemmelgarn

Back to faculty
ResearcherMedicineUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Latest papers

  • Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: protocol for a systematic review and network meta-analysis.

    Systematic reviews · 2013

  • Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis.

    Systematic reviews · 2013

  • Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis.

    Systematic reviews · 2013

All 8 publications

Latest funding

  • Drug Safety and Effectiveness Network Methods and Applications Group in Indirect Comparisons (DSEN MAGIC) Team

    CIHR · 2019 · Co-investigator

    $4,199,258
  • Economic impact of falls prevention interventions: We know the "value", but what about the "value for money"?

    CIHR · 2018 · Co-investigator

    $306,001
  • SPOR Evidence Alliance

    CIHR · 2017 · Co-investigator

    $4,996,890
All 15 grants and awards
Something wrong or missing on this profile? Suggest a correction